Skip to main content
Featured ArticlesNews ReelParabon Nanolabs

Parabon® NanoLabs to Hold Lecture for New Jersey Homicide Investigators Association

How to Use DNA Phenotyping in An Investigation” will be led by Parabon® NanoLabs Vice President Paula Armentrout Wednesday, 6 Sept., 2017.

Reston, Va. (Aug. 2017) – Parabon® NanoLabs, a vertically integrated DNA technology company that develops next-gen forensic and therapeutic products, will be leading a lecture for the New Jersey Homicide Investigators Association (NJHIA), held at the Monmouth County Prosecutor’s Office in Freehold, New Jersey. The lecture, “How to Use DNA Phenotyping in an Investigation,” will be led by Parabon’s vice president, Paula Armentrout, on Wednesday, 6 Sept., 2017, at 8 a.m.

Armentrout will describe Snapshot™, the company’s DNA phenotyping system, a revolutionary new forensics capability that accurately predicts ancestry and physical appearance from DNA evidence. It can also determine kinship between DNA samples. She will also discuss how the service can aid in generating investigative leads, narrowing suspect lists and identifying unknown remains.

This event is for NJHIA members only. In order to become a member, visit and click on join under the “Member” tab. People can also join the NJHIA at the morning of check-in and registration for the event.

The NJHIA was established to promote quality homicide investigations within the state of New Jersey, as well as establish a network for other law enforcement agencies across the United States. It supports its members by providing regular training sessions, workshops and special investigative seminars.

About Parabon® NanoLabs, Inc.:

Parabon® NanoLabs is a vertically integrated DNA technology company that develops next-generation forensic and therapeutic products, which leverage the enormous power of DNA. Staffed by a uniquely qualified team of scientists and technologists, with expertise ranging from bioinformatics and oncology to chemistry and computer science, the Company is bringing to market revolutionary new products and services made possible by recent advances in DNA sequencing, processing and manufacturing technologies.